FORT
LAUDERDALE, Fla. and Sacramento,
Calif., March 16, 2023 /PRNewswire/ -- Gemini
BioProducts Holding, Inc. ("GeminiBio" or the "Company"), a
portfolio company of BelHealth Investment Partners, LLC
("BelHealth"), a Florida-based
healthcare private equity firm, announced the appointment of
Cory Stevenson as Executive Chairman
of the Board of Directors.
GeminiBio Appoints Industry Veteran Cory
Stevenson as Executive Chairman
Mr. Stevenson joined the Board of GeminiBio in 2022 and has been
working closely with the GeminiBio management team as they prepare
to complete a three-phase buildout that addresses the long-term
capacity needs in the biopharma and cell/gene therapy marketplace.
Previously, Mr. Stevenson served as President of the BioProduction
Division of Thermo Fisher Scientific (NYSE:TMO), a world leader in
serving the biopharma sector, with annual revenue of more than
$40 billion. During Cory's tenure,
the BioProduction business grew from $200
million in revenues to over $2.5
billion annually.
Harold S. Blue, Managing Partner
of BelHealth Investment Partners said, "We are fortunate to have
Cory expand his role and guide our strategy at GeminiBio. Cory has
been very helpful during the last year as a board member and I am
excited that he will be taking a more active role. Also, given that
Cory worked directly with GeminiBio's CEO, Brian Parker, while at Thermo Fisher, this was a
natural fit."
Cory Stevenson, Executive
Chairman of GeminiBio added, "I am delighted to expand my role at
GeminiBio after working closely with Brian and the rest of the team
since I joined the Board. With the completion of its
57,000-square-foot manufacturing facilities, GeminiBio is
positioning itself as a vendor delivering much-needed critical
solutions to the global biopharma industry. I am looking forward to
this exciting next phase at GeminiBio."
About BelHealth Investment Partners
BelHealth Investment Partners, based in Fort Lauderdale, Florida, is a healthcare
private equity firm focused on lower middle market companies.
BelHealth has a unique combination of investing, executive
management, and entrepreneurial experience. BelHealth acquires
majority positions in entrepreneur-owned companies that it believes
will benefit from its extensive operating and private equity
investment expertise. For more information, visit
www.belhealth.com.
About GeminiBio
Founded in 1985, GeminiBio serves the global biotechnology
industry, from basic research to commercial production, with a
focus on helping our customers accelerate the development of life
enhancing biotherapeutics by streamlining and improving their cell
culture and process liquid manufacturing workflows. The company's
products are organized into two core verticals – Cell Culture
Solutions and Process Liquid Solutions. Located in West Sacramento, California, GeminiBio has
57,000 square feet of cGMP manufacturing space that is segregated
between animal origin free and animal component manufacturing.
GeminiBio is an ISO 13485 certified, FDA registered Class 1 Medical
Device Manufacturer, aligned with 21 CFR Part 820. For more
information, visit www.geminibio.com.
Contact:
BelHealth: Inder Tallur,
itallur@belhealth.com
GeminiBio: bparker@geminibio.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/geminibio-appoints-industry-veteran-cory-stevenson-as-executive-chairman-301774586.html
SOURCE BelHealth Investment Partners